DNAシーケンシング製品市場レポート：製品タイプ別、用途別、エンドユーザー別、地域別、2024-2032年

世界のDNAシーケンシング製品市場規模は2023年に69億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに155億米ドルに達し、2024年から2032年の間に9％の成長率（CAGR）を示すと予測しています。家系検査や系図への関心の高まり、クラウドベースやAI主導のバイオインフォマティクスソリューションの出現、非侵襲的出生前検査やがん診断へのDNAシーケンシングの統合の高まり、学術機関、医療プロバイダー、バイオテクノロジー企業間の協力関係の高まりなどが、市場を後押しする要因の一部です。

DNAシーケンシング製品は、遺伝学と分子生物学の分野に革命をもたらした最先端技術です。これらの製品は、DNA分子内のヌクレオチドの正確な順序を決定することを可能にし、生物の遺伝子構成に関する貴重な洞察を提供します。DNAシーケンシングは、遺伝子研究、個別化医療、法医学、遺伝性疾患の研究など、さまざまな科学・医療用途で重要な役割を果たしています。伝統的なサンガーシーケンシングから最新の高スループット次世代シーケンシング（NGS）プラットフォームまで、さまざまなタイプのDNAシーケンシング製品が利用可能です。先駆的な手法であるサンガーシーケンシングは、特定の用途には依然として適していますが、NGSは迅速でコスト効率に優れ、高スループットのシーケンシング機能を提供します。これらの製品は絶えず進化しており、進歩によって精度が向上し、リード長が長くなり、コストが削減されています。その結果、さまざまな分野で不可欠なツールとなり、画期的な発見を促し、精密医療や生命の遺伝的基盤の理解の進歩に貢献しています。

DNAシーケンシング技術の急速な進歩が市場に大きく貢献しています。特に次世代シーケンシング（NGS）プラットフォームは、迅速、高スループット、コスト効率の高いシーケンシング機能を提供することでこの分野に革命をもたらし、DNAシーケンシングを研究者、臨床医、さらには消費者にとってもより身近なものにしました。さらに、多様な分野でDNAシーケンシングの応用が拡大していることも、市場の成長に寄与しています。研究では、DNAシーケンシングがさまざまな生物のゲノム探索に使用され、遺伝学、進化、疾病メカニズムの重要な発見につながります。DNAシーケンシングは医療において、個別化医療、遺伝子検査、希少遺伝性疾患の診断に使用され、医療界におけるこれらの製品に対する需要を促進しています。さらに、遺伝性疾患の有病率の増加や、予防医療のための遺伝子検査の重要性に対する意識の高まりも、DNAシーケンシング製品の市場成長に拍車をかけています。法医学分析や農作物改良のための農業におけるDNAシーケンシングは、その市場範囲を拡大しています。また、シーケンシング技術プロバイダーと研究機関との連携や提携が、製品開発と採用を加速させています。その結果、シーケンシング精度、リード長、データ解析能力の継続的な向上が市場を活性化しています。さらに、政府のイニシアチブ、ゲノム研究に対する資金援助、DNAシーケンシングに関連するコストの低下により、これらの製品がより多くの人々に利用しやすくなり、市場の拡大をさらに促進しています。

DNAシーケンシング製品の市場動向と促進要因：

慢性疾患および遺伝性疾患の有病率の増加

慢性疾患と遺伝性疾患の有病率の増加は、市場を活性化する重要な要因となっています。これらの健康状態は世界人口の大部分に影響を与え続けているため、効果的な治療と管理を促進するための正確で早期診断の必要性が高まっています。DNAシーケンシングは、慢性疾患や障害に関連する遺伝子変異や突然変異を特定する上で極めて重要です。個人のDNAを分析することで、医療専門家はこれらの疾患の発症に寄与する特定の遺伝的要因を突き止めることができ、その人固有の遺伝的構成に基づく個別化治療計画が可能になります。さらに、疾患の遺伝的基盤の理解が進むにつれて、DNAシーケンシングは、リスクのある個人の早期スクリーニングや予測検査に不可欠となります。遺伝的素因の早期発見により、個人やその医療プロバイダーは、これらの疾患の影響を予防または軽減するための予防措置を講じることができるようになります。研究者、臨床医、消費者が、医療を変革し、慢性疾患や遺伝性疾患に罹患した患者の転帰を改善する上で遺伝子情報の可能性を認識するにつれて、これらの製品に対する需要は拡大し続けると思われます。

医薬品研究および医薬品開発におけるDNAシーケンシングの採用増加

医薬品研究および医薬品開発におけるDNAシーケンシングの採用の高まりが市場を促進しています。DNAシーケンシングは、疾患の遺伝的基盤や潜在的な治療標的に関する貴重な洞察を提供することで、創薬プロセスに革命をもたらしました。次世代シーケンシング（NGS）技術により、研究者は大規模なゲノム調査を実施し、特定の疾患や薬剤反応に関連する遺伝子変異を効率的に特定できます。DNAシーケンシングにより、患者の層別化に役立つバイオマーカーの同定が可能になり、製薬企業がより的を絞った臨床試験を計画・実施するのに役立ちます。さらに、DNAシーケンシングにより、希少疾患の研究や、以前はとらえどころのなかった新規創薬ターゲットの発見が容易になります。これにより、研究者はこれまでにない詳細なレベルで疾患の根本的な分子メカニズムを理解できるようになり、プレシジョン・メディシンの開発への道が開かれます。製薬会社が医薬品開発におけるゲノミクスの価値をますます認識するにつれて、DNAシーケンシング製品の需要は引き続き進展し、医薬品研究の進展と革新的な治療法の市場投入において極めて重要な役割を果たすと予想されます。

農業分野での使用拡大

農業におけるDNAシーケンシング製品の利用の拡大が市場成長の原動力となっています。DNAシーケンシング技術は、作物、家畜、農業害虫の正確かつ効率的なゲノム解析を可能にすることで、農業業界に革命をもたらしました。作物の改良において、DNAシーケンシングは、耐病性、収量ポテンシャル、栄養成分などの望ましい形質に関連する遺伝マーカーを特定する上で極めて重要です。この情報は、育種家がマーカー支援選抜によって新品種を開発する際に役立ち、育種プロセスを加速し、作物のパフォーマンスを向上させます。DNAシーケンシングは、家畜の遺伝的多様性と、家畜種の望ましい形質を強化する育種プログラムの可能性を理解するのに役立ちます。その結果、生産性の向上や動物の健康状態の改善につながります。さらに、DNAシーケンシングは農業害虫や病原菌の研究に役立っており、有害な化学薬品の使用を減らし、持続可能な農業を促進する、的を絞った害虫管理戦略の開発を可能にしています。農業部門が生産性と持続可能性を高めるための革新的で効率的な方法を模索する中、DNAシーケンシング製品に対する需要はさらに増加し、農業の進歩を促進し、世界の食糧安全保障に貢献することが期待されます。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 DNAシーケンシング製品の世界市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：製品タイプ別
• 市場内訳：用途別
• 市場内訳：エンドユーザー別
• 市場内訳：技術別
• 市場内訳：地域別
• 市場予測
• SWOT分析
  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威
• バリューチェーン分析
  • 研究開発
  • 原料調達
  • 製造
  • 流通
  • 最終用途
• ポーターのファイブフォース分析
  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第6章 市場内訳：製品タイプ別

• 消耗品・試薬
  • 市場動向
  • 市場予測
• 機器
  • 市場動向
  • 市場予測

第7章 市場内訳：用途別

• バイオマーカー
  • 市場動向
  • 市場予測
• 診断
  • 市場動向
  • 市場予測
• リプロダクティブヘルス
  • 市場動向
  • 市場予測
• フォレンジック
  • 市場動向
  • 市場予測
• 個別化医療
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：エンドユーザー別

• 学術・政府研究機関
  • 市場動向
  • 市場予測
• 製薬・バイオ企業
  • 市場動向
  • 市場予測
• 病院・クリニック
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：地域別

• 北米
  • 市場動向
  • 市場予測
• 欧州
  • 市場動向
  • 市場予測
• アジア太平洋
  • 市場動向
  • 市場予測
• ラテンアメリカ
  • 市場動向
  • 市場予測
• 中東・アフリカ
  • 市場動向
  • 市場予測

第10章 競合情勢

• 市場
• 市場内訳：主要企業別
• 主要企業のプロファイル
  • Illumina Inc
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pacific Biosciences of California, Inc.
  • Beckman Coulter

List of Figures

• Figure 1: Global: DNA Sequencing Products Market: Major Drivers and Challenges
• Figure 2: Global: DNA Sequencing Products Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: DNA Sequencing Products Market: Breakup by Product Type (in %), 2023
• Figure 4: Global: DNA Sequencing Products Market: Breakup by Application (in %), 2023
• Figure 5: Global: DNA Sequencing Products Market: Breakup by End-User (in %), 2023
• Figure 6: Global: DNA Sequencing Products Market: Breakup by Technology (in %), 2023
• Figure 7: Global: DNA Sequencing Products Market: Breakup by Region (in %), 2023
• Figure 8: Global: DNA Sequencing Products Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 9: Global: DNA Sequencing Products Industry: SWOT Analysis
• Figure 10: Global: DNA Sequencing Products Industry: Value Chain Analysis
• Figure 11: Global: DNA Sequencing Products Industry: Porter's Five Forces Analysis
• Figure 12: Global: DNA Sequencing Products Market: Consumables and Reagents (in Million US$), 2018 & 2023
• Figure 13: Global: DNA Sequencing Products Market Forecast: Consumables and Reagents (in Million US$), 2024-2032
• Figure 14: Global: DNA Sequencing Products Market: Equipments (in Million US$), 2018 & 2023
• Figure 15: Global: DNA Sequencing Products Market Forecast: Equipments (in Million US$), 2024-2032
• Figure 16: Global: DNA Sequencing Products Market (Applications in Biomarkers): Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: DNA Sequencing Products Market Forecast (Applications in Biomarkers): Sales Value (in Million US$), 2024-2032
• Figure 18: Global: DNA Sequencing Products Market (Applications in Diagnostics): Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: DNA Sequencing Products Market Forecast (Applications in Diagnostics): Sales Value (in Million US$), 2024-2032
• Figure 20: Global: DNA Sequencing Products Market (Application in Reproductive Health): Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: DNA Sequencing Products Market Forecast (Applications in Reproductive Health): Sales Value (in Million US$), 2024-2032
• Figure 22: Global: DNA Sequencing Products Market (Applications in Forensics): Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: DNA Sequencing Products Market Forecast (Applications in Forensics): Sales Value (in Million US$), 2024-2032
• Figure 24: Global: DNA Sequencing Products Market (Applications in Personalized Medicine): Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: DNA Sequencing Products Market Forecast (Applications in Personalized Medicine): Sales Value (in Million US$), 2024-2032
• Figure 26: Global: DNA Sequencing Products Market (Other Applications): Sales Value (in Million US$), 2018 & 2023
• Figure 27: Global: DNA Sequencing Products Market Forecast (Other Applications): Sales Value (in Million US$), 2024-2032
• Figure 28: Global: DNA Sequencing Products Market (in Academic and Government Research Institutes): Sales Value (in Million US$), 2018 & 2023
• Figure 29: Global: DNA Sequencing Products Market Forecast (in Academic and Government Research Institutes): Sales Value (in Million US$), 2024-2032
• Figure 30: Global: DNA Sequencing Products Market (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2018 & 2023
• Figure 31: Global: DNA Sequencing Products Market Forecast (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2024-2032
• Figure 32: Global: DNA Sequencing Products Market (in Hospitals and Clinics): Sales Value (in Million US$), 2018 & 2023
• Figure 33: Global: DNA Sequencing Products Market Forecast (in Hospitals and Clinics): Sales Value (in Million US$), 2024-2032
• Figure 34: Global: DNA Sequencing Products Market (Other End-Users): Sales Value (in Million US$), 2018 & 2023
• Figure 35: Global: DNA Sequencing Products Market Forecast (Other End-Users): Sales Value (in Million US$), 2024-2032
• Figure 36: North America: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: North America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: Europe: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: Europe: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Asia Pacific: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Asia Pacific: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Latin America: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Latin America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Middle East and Africa: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Middle East and Africa: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Global: DNA Sequencing Products Market: Breakup by Key Players (in %), 2023

List of Tables

• Table 1: Global: DNA Sequencing Products Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: DNA Sequencing Products Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
• Table 3: Global: DNA Sequencing Products Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: DNA Sequencing Products Market Forecast: Breakup by End-User (in Million US$), 2024-2032
• Table 5: Global: DNA Sequencing Products Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: DNA Sequencing Products Market: Competitive Structure
• Table 7: Global: DNA Sequencing Products Market: Key Players

Abstract

The global DNA sequencing products market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032. The increasing interest in ancestry testing and genealogy, the emergence of cloud-based and AI-driven bioinformatics solutions, the rising integration of DNA sequencing into non-invasive prenatal testing and cancer diagnostics, and the growing collaborations between academic institutions, healthcare providers, and biotechnology companies are some of the factors propelling the market.

DNA sequencing products are cutting-edge technologies that have revolutionized the field of genetics and molecular biology. These products enable the determination of the precise order of nucleotides in a DNA molecule, providing invaluable insights into the genetic makeup of organisms. DNA sequencing plays a crucial role in various scientific and medical applications, including gene research, personalized medicine, forensics, and the study of genetic diseases. Different types of DNA sequencing products are available, ranging from traditional Sanger sequencing to modern high-throughput Next-Generation Sequencing (NGS) platforms. Sanger sequencing, the pioneer method, remains relevant for certain applications, while NGS offers rapid, cost-effective, and high-throughput sequencing capabilities. These products are continually evolving, with advancements leading to improved accuracy, longer read lengths, and reduced costs. As a result, they have become indispensable tools in diverse fields, driving groundbreaking discoveries and contributing to advancements in precision medicine and our understanding of the genetic basis of life.

The rapid advancements in DNA sequencing technology are significantly contributing to the market. Next-Generation Sequencing (NGS) platforms, in particular, have revolutionized the field by providing rapid, high-throughput, and cost-effective sequencing capabilities, making DNA sequencing more accessible to researchers, clinicians, and even consumers. Furthermore, the expanding applications of DNA sequencing across diverse fields have contributed to market growth. In research, DNA sequencing is used to explore the genomes of various organisms, leading to significant discoveries in genetics, evolution, and disease mechanisms. DNA sequencing is employed in healthcare for personalized medicine, genetic testing, and diagnosis of rare genetic disorders, fostering demand for these products in the medical community. Moreover, the increasing prevalence of genetic diseases and the rising awareness of the importance of genetic testing for preventive healthcare have also fueled the market growth of DNA sequencing products. DNA sequencing in forensic analysis and agriculture for crop improvement has extended its market reach. Besides, collaborations and partnerships between sequencing technology providers and research institutions have accelerated product development and adoption. As a result, the continuous improvement in sequencing accuracy, read lengths, and data analysis capabilities have catalyzed the market. Additionally, the government's initiatives, funding support for genomic research, and decreasing costs associated with DNA sequencing have made these products more accessible to a broader audience, further stimulating market expansion.

DNA sequencing products Market Trends/Drivers:

Increasing prevalence of chronic diseases and genetic disorders

The increasing prevalence of chronic diseases and genetic disorders has become a significant factor catalyzing the market. As these health conditions continue to affect a large portion of the global population, there is a growing need for accurate and early diagnosis to facilitate effective treatment and management. DNA sequencing is crucial in identifying genetic variations and mutations associated with chronic diseases and disorders. By analyzing an individual's DNA, healthcare professionals can pinpoint specific genetic factors contributing to the development of these conditions, enabling personalized treatment plans based on a person's unique genetic makeup. Moreover, as the understanding of the genetic basis of diseases advances, DNA sequencing becomes essential in early screening and predictive testing for individuals at risk. Early detection of genetic predispositions empowers individuals and their healthcare providers to take proactive measures to prevent or mitigate the impact of these diseases. The demand for these products is likely to continue growing as researchers, clinicians, and consumers recognize the potential of genetic information in transforming healthcare and improving patient outcomes for those affected by chronic diseases and genetic disorders.

Rising adoption of DNA sequencing in pharmaceutical research and drug development

The rising adoption of DNA sequencing in pharmaceutical research and drug development is propelling the market. DNA sequencing has revolutionized the drug discovery process by providing invaluable insights into the genetic basis of diseases and potential therapeutic targets. With Next-Generation Sequencing (NGS) technologies, researchers can perform large-scale genomic studies and efficiently identify genetic variations associated with specific diseases or drug responses. DNA sequencing enables the identification of biomarkers that can aid in patient stratification, helping pharmaceutical companies design and conduct more targeted clinical trials. Additionally, DNA sequencing facilitates the study of rare diseases and the discovery of novel drug targets that were previously elusive. It allows researchers to understand the underlying molecular mechanisms of diseases at a level of detail never before possible, paving the way for the development of precision medicines. As pharmaceutical companies increasingly recognize the value of genomics in drug development, the demand for DNA sequencing products is expected to continue progressing, playing a pivotal role in advancing pharmaceutical research and bringing innovative therapies to the market.

Growing use of these products in agriculture

The growing use of DNA sequencing products in agriculture has driven the market growth. DNA sequencing technologies have revolutionized the agricultural industry by enabling precise and efficient genomic analysis of crops, livestock, and agricultural pests. In crop improvement, DNA sequencing is crucial in identifying genetic markers associated with desirable traits such as disease resistance, yield potential, and nutritional content. This information aids breeders in developing new varieties through marker-assisted selection, accelerating the breeding process and improving crop performance. DNA sequencing helps livestock understand the genetic diversity and potential for breeding programs to enhance desirable traits in livestock species. This, in turn, can lead to increased productivity and improved animal health. Furthermore, DNA sequencing is instrumental in studying agricultural pests and pathogens, enabling the development of targeted pest management strategies that reduce the use of harmful chemicals and promote sustainable agriculture. As the agricultural sector seeks innovative and efficient ways to enhance productivity and sustainability, the demand for DNA sequencing products is expected to increase further, driving advancements in agriculture and contributing to global food security.

DNA Sequencing Products Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global DNA sequencing products market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, application and end-user.

Breakup by Product Type:

Consumables and Reagents

Equipments

Consumables and reagents dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables and reagents, and equipment. According to the report, consumables and reagents represented the largest segment.

The consumables and reagents encompass various essential components and materials for conducting DNA sequencing experiments and analysis. Consumables include items like DNA extraction kits, sequencing libraries, and flow cells, while reagents consist of chemical substances and enzymes required during the sequencing process. The significance of this market segment lies in its vital role in facilitating DNA sequencing procedures, making it a crucial investment for researchers, clinicians, and other users.

As DNA sequencing technologies evolve and advance, the demand for high-quality and specialized consumables and reagents augments, thereby contributing to the segment's substantial growth. Moreover, the consumables and reagents segment often enjoys a higher return on investment for manufacturers, as researchers and laboratories require regular restocking of these items to sustain their sequencing operations. As the DNA sequencing market expands, this segment is expected to maintain its dominance and contribute significantly to the overall revenue of the industry.

Breakup by Application:

Biomarkers

Diagnostics

Reproductive Health

Forensics

Personalized Medicine

Others

Biomarkers dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes biomarkers, diagnostics, reproductive health, forensics, personalized medicine, and others. According to the report, biomarkers represented the largest segment.

Biomarkers are specific genetic, biochemical, or molecular characteristics that provide valuable insights into an individual's health status and treatment response. In the realm of DNA sequencing, biomarkers hold immense importance, especially in personalized medicine. Biomarkers derived from DNA sequencing data aid in predicting treatment outcomes, enabling healthcare professionals to tailor therapies based on a patient's genetic profile. This personalized approach enhances treatment efficacy and minimizes adverse effects, optimizing patient outcomes.

The popularity of biomarkers in DNA sequencing products is driven by the increasing understanding of the link between genetics and disease, making them valuable tools in diagnostics, prognostics, and therapeutic decision-making. As the field of genomics continues to advance and more biomarkers are identified, the demand for DNA sequencing products, particularly those focused on biomarker analysis, is expected to grow significantly, further solidifying its prominent position in the market segment.

Breakup by End-User:

Academic and Government Research Institutes

Pharmaceutical and Biotechnology Companies

Hospitals and Clinics

Others

Academic and government research institutes dominate the market

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. According to the report, academic and government research institutes represented the largest segment.

DNA sequencing products are currently experiencing significant utilization in academic and government research institutes. This trend can be attributed to the abundant research and development projects in these institutions that involve practical data analysis implementations and next-generation sequencing (NGS). Academic and government research institutes are at the forefront of scientific exploration. DNA sequencing plays a crucial role in various areas of study, including genomics, molecular biology, agriculture, and healthcare research.

The accessibility of advanced DNA sequencing technologies and the expertise of researchers in these institutions contribute to the widespread adoption of these products. Furthermore, these research institutes often collaborate with DNA sequencing companies, fostering partnerships that promote innovation and enhance product development. As a result, the demand for these products remains robust in the academic and government sectors, driving market growth and facilitating groundbreaking discoveries and advancements in scientific knowledge and applications.

Breakup by Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the DNA sequencing products largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market.

The North American region is dominant in the global market. This can be attributed to several key factors driving the market growth in the region. The region has a substantial geriatric population, leading to an increased demand for genetic testing and personalized medicine to address age-related health concerns. Furthermore, the prevalence of various chronic diseases in North America has bolstered the adoption of DNA sequencing products for diagnostics, prognosis, and treatment decision-making. DNA sequencing is vital in identifying genetic factors contributing to these diseases, enabling targeted therapies and precision medicine approaches. Moreover, the region has several prominent drug manufacturers and biotechnology companies actively involved in genomic research and drug development. The presence of such industry players drives the demand for these products to support their research and clinical trials.

Competitive Landscape:

Top companies are bolstering market growth through several strategic approaches. They invest heavily in research and development to continuously improve their sequencing technologies, enhancing accuracy and scalability and reducing costs. This ensures that their products remain at the forefront of innovation and appeal to a broader customer base. Furthermore, these companies actively collaborate with academic institutions, research organizations, and healthcare providers to expand their customer reach and foster partnerships that drive product development and application. Additionally, they focus on expanding their product portfolios to cater to various customer needs, offering a range of DNA sequencing solutions tailored for different applications and industries. Moreover, effective marketing strategies, including targeted advertising, educational campaigns, and endorsements from key opinion leaders, create awareness and drive demand for their products. By employing these strategies and staying at the forefront of technological advancements, the top companies propel market growth and play a pivotal role in advancing genomics research, healthcare, agriculture, and other fields.

The report has provided a comprehensive analysis of the competitive landscape in the DNA sequencing products market. Detailed profiles of all major companies have also been provided.

Illumina Inc.

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd.

Pacific Biosciences of California, Inc.

Beckman Coulter

Recent Developments:

In 2019, Illumina announced a collaboration with Bristol-Myers Squibb to develop companion diagnostics for oncology treatments. The companies aimed to leverage Illumina's sequencing technology to identify genomic biomarkers that could help predict patient responses to specific cancer therapies.

In 2019, Thermo Fisher Scientific partnered with West China Hospital of Sichuan University to establish a Joint Precision Medicine Research Laboratory in China. The collaboration aimed to advance precision medicine research by integrating Thermo Fisher's genetic sequencing solutions with the hospital's clinical expertise.

In 2018, Roche announced a collaboration with Foundation Medicine, Inc. to develop and distribute FoundationOne CDx, a comprehensive genomic profiling assay. The collaboration aimed to expand access to comprehensive genomic testing for cancer patients and guide personalized treatment decisions.

Key Questions Answered in This Report

• 1. What was the size of the global DNA sequencing products market in 2023?
• 2. What is the expected growth rate of the global DNA sequencing products market during 2024-2032?
• 3. What are the key factors driving the global DNA sequencing products market?
• 4. What has been the impact of COVID-19 on the global DNA sequencing products market?
• 5. What is the breakup of the global DNA sequencing products market based on the product type?
• 6. What is the breakup of the global DNA sequencing products market based on the application?
• 7. What is the breakup of the global DNA sequencing products market based on the end-user?
• 8. What are the key regions in the global DNA sequencing products market?
• 9. Who are the key players/companies in the global DNA sequencing products market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global DNA Sequencing Products Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product Type
• 5.5 Market Breakup by Application
• 5.6 Market Breakup by End-User
• 5.7 Market Breakup by Technology
• 5.8 Market Breakup by Region
• 5.9 Market Forecast
• 5.10 SWOT Analysis
  • 5.10.1 Overview
  • 5.10.2 Strengths
  • 5.10.3 Weaknesses
  • 5.10.4 Opportunities
  • 5.10.5 Threats
• 5.11 Value Chain Analysis
  • 5.11.1 Research and Development
  • 5.11.2 Raw Material Procurement
  • 5.11.3 Manufacturing
  • 5.11.4 Distribution
  • 5.11.5 End-Use
• 5.12 Porters Five Forces Analysis
  • 5.12.1 Overview
  • 5.12.2 Bargaining Power of Buyers
  • 5.12.3 Bargaining Power of Suppliers
  • 5.12.4 Degree of Competition
  • 5.12.5 Threat of New Entrants
  • 5.12.6 Threat of Substitutes

6 Market Breakup by Product Type

• 6.1 Consumables and Reagents
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Equipments
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Biomarkers
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Reproductive Health
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Forensics
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Personalized Medicine
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by End-User

• 8.1 Academic and Government Research Institutes
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceutical and Biotechnology Companies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hospitals and Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Europe
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Asia Pacific
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Competitive Landscape

• 10.1 Market Structure
• 10.2 Market Breakup by Key Players
• 10.3 Profiles of Key Players
  • 10.3.1 Illumina Inc
    • 10.3.1.1 Company Overview
    • 10.3.1.2 Description
    • 10.3.1.3 Product Portfolio
    • 10.3.1.4 Financials
    • 10.3.1.5 SWOT Analysis
  • 10.3.2 Thermo Fisher Scientific Inc.
    • 10.3.2.1 Company Overview
    • 10.3.2.2 Description
    • 10.3.2.3 Product Portfolio
    • 10.3.2.4 Financials
    • 10.3.2.5 SWOT Analysis
  • 10.3.3 F. Hoffmann-La Roche Ltd.
    • 10.3.3.1 Company Overview
    • 10.3.3.2 Description
    • 10.3.3.3 Product Portfolio
    • 10.3.3.4 Financials
    • 10.3.3.5 SWOT Analysis
  • 10.3.4 Pacific Biosciences of California, Inc.
    • 10.3.4.1 Company Overview
    • 10.3.4.2 Description
    • 10.3.4.3 Product Portfolio
    • 10.3.4.4 Financials
    • 10.3.4.5 SWOT Analysis
  • 10.3.5 Beckman Coulter
    • 10.3.5.1 Company Overview
    • 10.3.5.2 Description
    • 10.3.5.3 Product Portfolio
    • 10.3.5.4 Financials
    • 10.3.5.5 SWOT Analysis